BioHarvest SciencesBHST.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, BioHarvest Sciences (BHST.O) trades at a negative P/E (-3.79x, due to a recent net loss), P/B of 2.13x, P/S of 1.18x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B sits at the 14th percentile over the trailing 10Y window (vs. 14th percentile over 3Y); P/S sits at the 8th percentile over the trailing 10Y window (vs. 8th percentile over 3Y).
Cross-sectional valuation: its P/B ranks at the 48th percentile within its industry and the 60th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Relative to industry peers, its P/B shows a deeper discount than it does against the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. BioHarvest Sciences operates in the Manufacturing sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: BHST · BHST
Want the full picture on whether BioHarvest Sciences (BHST.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | -3.79 | Negative | Negative | Negative | Negative | Negative | Negative |
| P/B (MRQ) | 2.13 | ||||||
| P/S (TTM) | 1.18 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |